Stay updated on DSP-5336 in Relapsed AML Clinical Trial
Sign up to get notified when there's something new on the DSP-5336 in Relapsed AML Clinical Trial page.

Latest updates to the DSP-5336 in Relapsed AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page's Locations section was updated to add numerous sites across multiple states and countries, and the page revision was updated to v3.3.3, while the HHS Vulnerability Disclosure link was removed.SummaryDifference0.8%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedMinor site revision from v3.3.1 to v3.3.2 observed on the page; no changes to the study details or navigation are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.1 in the footer, with no other changes to core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedAdded recruitment site in Tainan, Taiwan. Updated Taiwan location naming from Tainan City, Taiwan to Tainan, Taiwan.SummaryDifference0.1%

- Check63 days agoChange DetectedThe Study Details page appears functionally unchanged; core sections such as overview, design, eligibility, and locations remain the same, with only minor visual formatting tweaks.SummaryDifference0.1%

- Check92 days agoChange DetectedAdded a funding-status notice and updated version to v3.2.0; removed older version reference and a specific disease name (Acute lymphoid leukemia).SummaryDifference2%

Stay in the know with updates to DSP-5336 in Relapsed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DSP-5336 in Relapsed AML Clinical Trial page.